1. Home
  2. RMNI vs TARA Comparison

RMNI vs TARA Comparison

Compare RMNI & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rimini Street Inc. (DE)

RMNI

Rimini Street Inc. (DE)

HOLD

Current Price

$3.82

Market Cap

307.1M

ML Signal

HOLD

Logo Protara Therapeutics Inc.

TARA

Protara Therapeutics Inc.

HOLD

Current Price

$4.65

Market Cap

269.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RMNI
TARA
Founded
2005
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
307.1M
269.8M
IPO Year
2015
2014

Fundamental Metrics

Financial Performance
Metric
RMNI
TARA
Price
$3.82
$4.65
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$5.00
$24.40
AVG Volume (30 Days)
451.7K
753.3K
Earning Date
04-30-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
197.50
38.25
EPS
0.01
N/A
Revenue
$431,496,000.00
$2,948,000.00
Revenue This Year
$6.02
N/A
Revenue Next Year
$5.50
N/A
P/E Ratio
$380.00
N/A
Revenue Growth
5.33
N/A
52 Week Low
$2.87
$2.77
52 Week High
$5.38
$7.82

Technical Indicators

Market Signals
Indicator
RMNI
TARA
Relative Strength Index (RSI) 58.69 41.65
Support Level $3.36 $4.21
Resistance Level $4.14 $5.53
Average True Range (ATR) 0.14 0.31
MACD 0.01 -0.03
Stochastic Oscillator 69.35 33.20

Price Performance

Historical Comparison
RMNI
TARA

About RMNI Rimini Street Inc. (DE)

Rimini Street Inc and its subsidiaries are providers of end-to-end enterprise software support, products, and services. The company offers a comprehensive family of unified solutions to run, manage, support, customize, configure, connect, protect, monitor, and optimize clients' enterprise applications, databases, and technology software platforms. The company derives revenues from clients by providing subscription support services for enterprise resource planning, customer relationship management, product lifecycle management, database, and technology software systems. Geographically, the company generates its revenue from the United States of America and the International market.

About TARA Protara Therapeutics Inc.

Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.

Share on Social Networks: